AndzonBio2 at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

AndzonBio2 at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
andzonbio2.com
Biotech
Develops early-stage therapies aimed at neuroinflammation in neurological and neurodegenerative diseases.
Talk
Tue Nov 10
13:00–13:15
CNS/Neurology: AndzonBio2
Early-stage small molecule drugs that dampen brain inflammation behind neurological disorders, including a program licensed from the University of Cambridge.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from AndzonBio2

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction